Skip to main content

Table 1 Patient characteristics at baseline

From: General practitioner practice-based pharmacist input to medicines optimisation in the UK: pragmatic, multicenter, randomised, controlled trial

Variable

Total

Control

Intervention

p value

 

N = 356

n = 175

(49.2%)

n = 181

(50.8%)

Stratum

   

0.752a

 1 [n (%)]

229 (64.3)

114 (65.1)

115 (63.5)

 

 2 [n (%)]

127 (35.7)

61 (34.9)

66 (36.5)

 

Age: [mean years ± SD]

67.9 ± 13.1

67.5 ± 12.6

68.5 ± 13.5

0.275b

 Median [IQR]

70 [60.0–78.0]

69 [60.0–77.0]

71 [61.0–78.5]

 

 18–65 years [n (%)]

126 (35.4)

63 (36.0)

63 (34.8)

 

 > 65 years [n (%)]

230 (64.6)

112 (64.0)

118 (65.2)

 

 Range

25–96

26–94

25–96

 

Sex

   

0.442a

 Female [n (%)]

192 (53.9)

98 (56.0)

94 (51.9)

 

 Male [n (%)]

164 (46.1)

77 (44.0)

87 (48.1)

 

Number of active medical problems: [mean ± SD]

7.6 ± 3.4

7.9 ± 3.6

7.3 ± 3.3

0.043b

Median [IQR]

7 [5–10]

8 [5–10]

6 [5–9]

 

Number of repeat medicines: [mean ± SD]

10.3 ± 3.6

10.3 ± 3.5

10.3 ± 3.7

0.787b

Median [IQR]

10 [8–12]

10 [8–12]

10 [8–12]

  1. SD standard deviation, IQR interquartile range
  2. aChi-square test
  3. bMann–Whitney U test